3. Summary
Global Markets Direct’s, Genital Warts (Condylomata Acuminata) - Pipeline
Review, H2 2012, provides an overview of the indication’s therapeutic
pipeline. This report provides information on the therapeutic development
for Genital Warts (Condylomata Acuminata), complete with latest updates,
and special features on late-stage and discontinued projects. It also reviews
key players involved in the therapeutic development for Genital Warts
(Condylomata Acuminata). Genital Warts (Condylomata Acuminata) -
Pipeline Review, Half Year is built using data and information sourced from
Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases
from company/university sites and industry-specific third party sources,
put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Genital Warts (Condylomata
Acuminata).
- A review of the Genital Warts (Condylomata Acuminata) products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Genital Warts (Condylomata Acuminata).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
5. Table of Contents :
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Genital Warts (Condylomata Acuminata) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Genital Warts (Condylomata
Acuminata) 7
Genital Warts (Condylomata Acuminata) Therapeutics under Development
by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Discovery and Pre-Clinical Stage Products 13
Comparative Analysis 13
Genital Warts (Condylomata Acuminata) Therapeutics – Products under
Development by Companies 14…………….
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline
Review, H2 2012&PubId=&pagenum=1